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[Coronary aneurysm is rarely found during coronary angiog-
aphy. Systemic inﬂammatory disease such as Kawasaki disease
1,2] and Behc¸ et’s disease [3] are possible causes of giant coro-
ary aneurysm. In addition, interventional procedures can also be
esponsible for iatorogenic coronary aneurysm (pseudoaneurysm).
oronary aneurysm has the potential risk for coronary rupture
2] as well as myocardial infarction due to coronary thromboem-
olism [4]. According to the Japanese guidelines for diagnosis
nd management of cardiovascular sequelae in Kawasaki disease,
ntithrombotic therapy using warfarin plus aspirin is recom-
ended for patients with giant coronary aneurysm to prevent
oronary thromboembolism [5]. Recently, Suda et al. reported that
he long-term prognosis of patients with Kawasaki disease com-
licated by giant coronary aneurysms is moderately good with
ultiple catheter or surgical interventions [6]. Despite the favor-
ble long-term prognosis, it is still unknown how to prevent
oronary rupture in patients with giant coronary aneurysms asso-
iated with systemic inﬂammatory diseases.
In this issue of the journal, Sooﬁ et al. report an interesting case
ith giant coronary aneurysm associated with Behc¸ et’s disease [7].
he huge coronary aneurysm and a severe stenotic lesion of the
eft anterior descending coronary artery were successfully treated
ith a drug-eluting stent and a polytetraﬂuoroethylene (PTFE)-
overed stent. Although PTFE-covered stent is a possible treatment
trategy for a giant coronary aneurysm, its use is limited to coro-
ary perforation in Japan. Also, it is uncertain if vasculitis affects
mplanted PTFE-covered stents. As the authors discuss in their case
eport, stenting to the coronary arteries with inﬂammation may
urther cause pseudoaneurysmal formation late after intervention.
herefore, the case should be carefully monitored using angiogra-
hy or multidetector computed tomography with respect to the
ong-term durability of the PTFE-covered stent. Another possible
ntervention to treat large coronary aneurysm like this case is a
oil embolization [8,9]. Recently, stent-assisted coil embolization
o treat fusiform [8] or saccular coronary aneurysm [9] have been
eported.
One of the limitations of this case report is a lack of intravascu-
ar ultrasound (IVUS) imaging. As the authors admitted, differential
iagnosis between true and pseudo-aneurysm could not be made
y coronary angiography alone. A previous IVUS study demon-
trated that only 27% of the angiographically diagnosed coronary
neurysms were categorized as “true” aneurysms and 4% were
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ttp://dx.doi.org/10.1016/j.jccase.2013.04.002categorized as “pseudo” aneurysms [10]. Although long-term dura-
bility of catheter-based interventions for giant coronary aneurysms
associated with systemic inﬂammatory diseases needs further
investigation, interventional cardiologists should be familiar with
these less invasive, possibly effective interventional strategies for
giant coronary aneurysm.
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